{
  "table_name": "action_type_30",
  "table_fullname": "bigquery-public-data.ebi_chembl.action_type_30",
  "column_names": [
    "type_action",
    "description",
    "type_parent"
  ],
  "column_types": [
    "STRING",
    "STRING",
    "STRING"
  ],
  "nested_column_names": [
    "type_action",
    "description",
    "type_parent"
  ],
  "nested_column_types": [
    "STRING",
    "STRING",
    "STRING"
  ],
  "description": [
    "Clé primaire. Type d'action du médicament par exemple, agoniste, antagoniste.",
    "Description de la façon dont le type d'action est utilisé",
    "Regroupement de niveau supérieur des types d'action par exemple, action positive vs action négative"
  ],
  "sample_rows": [
    {
      "type_action": "BINDING AGENT",
      "description": "Binds to a substance such as a cell surface antigen, targetting a drug to that location, but not necessarily affecting the functioning of the substance itself",
      "type_parent": "OTHER"
    },
    {
      "type_action": "CHELATING AGENT",
      "description": "Binds to a metal, reducing its availability for further interactions",
      "type_parent": "OTHER"
    },
    {
      "type_action": "CROSS-LINKING AGENT",
      "description": "Induces cross-linking of proteins or nucleic acids",
      "type_parent": "OTHER"
    },
    {
      "type_action": "DISRUPTING AGENT",
      "description": "Destabilises or disrupts a protein complex, macromolecular assembly, cell membrane etc",
      "type_parent": "OTHER"
    },
    {
      "type_action": "HYDROLYTIC ENZYME",
      "description": "Hydrolyses a substrate through enzymatic reaction",
      "type_parent": "OTHER"
    }
  ]
}